Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%<=C<2%
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% >=25% <25% >=10%
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
10%<=C<25%
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
*
General Information
Revision date
2022-12-19
Product name
Nalbuphine Hydrochloride Injection (Hospira Inc.)
Product name
Nalbuphine Hydrochloride Injection (Hospira Inc.)
Identification on the label/Trade name
Nalbuphine Hydrochloride Injection
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product used as Analgesic
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Hospira Australia Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Not Classified
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GHS - Classification Not classified as hazardous
Signal word
Not Classified
Hazard statements
Not classified in accordance with international standards for workplace safety.
Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.